JOIN OUR EMAIL LIST
Get exclusive deals and early access to new products.
A peer-reviewed meta-analysis of 25 years of clinical data just confirmed what dermatologists have known for decades. Here's the science — and what it means for your routine.
Walk into any skincare aisle and you'll find the same promises. Wildcrafted. Cold-pressed. Clinically inspired. Harvested at peak potency from somewhere remote and beautiful. The marketing is compelling. The results, according to a major 2024 meta-analysis, are not.
Researchers Cheng, Feng, and colleagues spent years reviewing every randomized controlled trial on plant-based topical skincare published between 2000 and 2024. What they found — published in the Journal of Cosmetic Dermatology and indexed on NIH’s PubMed — was consistent across 25 years of data: natural skincare produces no lasting structural improvement to the skin.
Here are the five reasons why — in plain English.
In 2000, researchers Bos and Meinardi identified what is now the governing principle of transdermal pharmacology: the 500 Dalton rule. Any molecule above 500 Daltons in molecular weight cannot pass through the stratum corneum — the outer layer of skin — regardless of how it’s formulated, how concentrated it is, or where it was sourced.
This isn’t a fringe theory. It’s the same standard pharmaceutical companies use when developing transdermal patches and topical drugs. The skin’s barrier exists specifically to keep things out. It is extraordinarily good at its job.
“The stratum corneum functions as a near-impenetrable barrier. Molecular weight is the primary determinant of percutaneous absorption.”
Bos & Meinardi, Experimental Dermatology, 2000Rosehip oil? Well above 500 Da. Sea buckthorn? Above. Most botanical extracts, plant polyphenols, and herbal complexes? All above the threshold. They reach the epidermis, provide temporary hydration, and go no further. Physics does not make exceptions for where something was grown.
The 2024 meta-analysis didn’t just find that botanicals underperform — it found they perform, briefly, and then stop. Participants using plant-based topicals showed improvements in skin hydration and short-term elasticity in the first few weeks of use.
By week eight, those improvements were statistically indistinguishable from baseline. The meta-analysis measured two primary structural outcomes: net elasticity (R5) and elastic recovery (R7). Both showed zero significant difference between botanical treatment groups and controls beyond eight weeks.
“No statistically significant differences were observed in R5 or R7 values at follow-up periods beyond eight weeks, suggesting no durable structural benefit from plant-based topical preparations.”
Cheng F., Feng J., et al., Journal of Cosmetic Dermatology, 2024Your skin feels better. The structural aging continues underneath. Those two things can both be true at the same time — and for 25 years of study participants, they were.
The visible signs of skin aging — lines, loss of firmness, changes in texture — originate in the dermis. This is where collagen is produced and degraded. Where elastin fibers determine skin’s resilience. Where the structural scaffold that holds everything up actually lives.
The dermis sits below the epidermis. To reach it, an ingredient has to cross the stratum corneum and pass through the full epidermal layer. This requires a molecular weight under 500 Daltons and, in most cases, a specific delivery mechanism designed for dermal penetration.
“Improvements in surface hydration do not correlate with structural dermal changes. The mechanisms governing epidermal moisture retention are distinct from those governing dermal collagen and elastin homeostasis.”
Cheng F., Feng J., et al., Journal of Cosmetic Dermatology, 2024Surface hydration is real. Your skin does feel better. But feeling better is not the same as structurally changing — and the dermis, where aging originates, is not being reached by the products most people are using.
“Wildcrafted at altitude.” “Cold-pressed from heritage seeds.” “Survived Arctic temperatures for 10,000 years.” These are stories about where an ingredient came from. They are not mechanisms of action. They have no relationship to whether the ingredient crosses the 500 Dalton threshold.
Neither does concentration. A 20% rosehip serum does not penetrate more deeply than a 5% rosehip serum. Both sit at the same molecular weight. Both reach the same layer. The only thing that changes with concentration is the quantity sitting on the surface of your epidermis.
“Botanical source, extraction method, and formulation concentration were not found to be significant predictors of dermal bioavailability. Molecular characteristics, particularly molecular weight, remained the dominant determinant.”
Cheng F., Feng J., et al., Journal of Cosmetic Dermatology, 2024The natural skincare industry has built a $200 billion category on origin stories. The research is unambiguous: where something comes from does not determine where it goes.
The most important finding in the 2024 meta-analysis isn’t any single data point. It’s the consistency. Cheng, Feng, and colleagues reviewed every relevant randomized controlled trial published over 25 years — across PubMed, Embase, Cochrane Library, and Web of Science. The studies came from different countries, different institutions, different botanicals, different formulations.
The structural outcome measures — the ones that indicate skin is actually, physically changing at a deeper level — showed no significant improvement. Not in some studies. In all of them. The pattern held across a quarter century of research.
“Despite heterogeneity in botanical agents studied, formulation approaches, and participant demographics, structural outcome measures demonstrated consistent non-significance across follow-up periods exceeding eight weeks.”
Cheng F., Feng J., et al., Journal of Cosmetic Dermatology, 2024This is not a niche finding. This is not one study with a small sample. This is the aggregate of 25 years of controlled research, systematically reviewed and published in a peer-reviewed journal indexed by the National Institutes of Health. The conclusion is not complicated: natural skincare does not produce lasting structural change to the skin.
The research doesn’t leave skincare without an answer — it redirects the question. The question was never “natural or synthetic.” It was always “does it reach the layer where it needs to work?”
Clinical-grade actives — ingredients that meet the 500 Dalton threshold and are selected for documented dermal mechanisms — do produce structural outcomes. Adenosine (267 Da) has been clinically shown to reduce fine line depth and improve elasticity at the dermal layer. Dipeptide-12 signals collagen production where collagen actually breaks down. EGF triggers cellular regeneration at the structural level.
These aren’t botanical alternatives. They are pharmaceutical-standard ingredients chosen because they have a documented mechanism and a molecular weight that allows them to reach the tissue where that mechanism operates. That’s the difference between a product that changes how your skin feels and one that changes what your skin actually is.
Nivora’s Rejuvenating Serum is formulated around clinical-grade actives — the same ingredients used in pharmaceutical and medical-grade dermatology — delivered via Korean fermentation science to the layer where aging actually happens.